Skip to content

๐€๐ˆ-๐ฉ๐จ๐ฐ๐ž๐ซ๐ž๐ ๐ญ๐ฎ๐ฆ๐จ๐ซ ๐๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง ๐๐ข๐ซ๐ž๐œ๐ญ๐ฅ๐ฒ ๐๐ฎ๐ซ๐ข๐ง๐  ๐œ๐š๐ง๐œ๐ž๐ซ ๐ฌ๐ฎ๐ซ๐ ๐ž๐ซ๐ฒ


In collaboration with strong partners, Katana Labs leverages its images analysis, Deep Learning model development and software engineering expertise to push the limits in AI-enabled precision diagnostics. Together with Refined Laser Systems GmbH, Universitรคtsklinikum Carl Gustav Carus Dresden and Technische Universitรคt Dresden, the German consortium initiated the ๐Š๐”๐‘๐„ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ to bring real-time, intraoperative histopathology-based tumor detection directly in the operating room.

The joint mission of this groundbreaking research study is to facilitate precise differentiation between healthy and cancerous tissue during surgery, thereby increasing the likelihood for successful tumor removal and reducing the overall time in surgery.

Today, confirming the successful surgical removal of all cancerous tissue often requires the dedicated histopathological analysis of samples in a pathology lab, including sample transport, preparation, staining, and expert review by one or more pathologists. This process takes time and often has to be repeated. During this histopathological analysis, the patient remains under anesthesia and the surgery is paused, limiting immediate decision-making by the responsible surgeon.

๐Ÿ‘‰ ๐Š๐”๐‘๐„ ๐š๐ข๐ฆ๐ฌ ๐ญ๐จ ๐œ๐ก๐š๐ง๐ ๐ž ๐ญ๐ก๐š๐ญ:
Refined Laser Systems GmbH’ label-free SRS microscopy system generates high-resolution molecular images of fresh tissue directly at the point of care in the operation room.

At Katana Labs, we develop the ๐€๐ˆ ๐š๐ฅ๐ ๐จ๐ซ๐ข๐ญ๐ก๐ฆ๐ฌ, ๐๐š๐ญ๐š ๐ข๐ง๐Ÿ๐ซ๐š๐ฌ๐ญ๐ซ๐ฎ๐œ๐ญ๐ฎ๐ซ๐ž, ๐š๐ง๐ ๐ฌ๐จ๐Ÿ๐ญ๐ฐ๐š๐ซ๐ž ๐ญ๐จ ๐š๐ง๐š๐ฅ๐ฒ๐ณ๐ž ๐ญ๐ก๐ข๐ฌ ๐ฅ๐š๐›๐ž๐ฅ-๐Ÿ๐ซ๐ž๐ž ๐ข๐ฆ๐š๐ ๐ข๐ง๐  ๐๐š๐ญ๐š ๐ข๐ง ๐ซ๐ž๐š๐ฅ ๐ญ๐ข๐ฆ๐ž. We train the AI models to automatically detect tumor regions in distinction to healthy tissue and provide structured, interpretable outputs that support surgeons and pathologists in decision-making during surgery.

๐“๐ก๐ž ๐ ๐จ๐š๐ฅ๐ฌ:
โœ” Immediate identification of cancerous tissue directly during surgery
โœ” AI-assisted decision support to inform the surgeon/pathologist with real-time histopathology data
โœ” Proof-of-principle for developing a scalable framework for broader applications in cancer surgery

The KURE project is funded by the Bundesministerium fรผr Bildung und Forschung under the ๐Š๐ˆ๐Ž๐ง ๐ฉ๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฆ๐ž, supporting AI innovations in healthcare.